Biotech Stocks

Features Diabetes is on the rise. Companies working to counter its effects stand to make big profits. Here, Tom Bulford looks at three small-cap biotech companies aiming to do just that.

By Tom Bulford Published 15 September 10

Features The field of 'regenerative medicine' has seen some incredible advances, and the market is set to take off, says Marc Lichtenfeld. Here, he explains how to play the sector and tips four potential winners.

By moneyweek Published 17 June 10